Logo image of FRGE

FORGE GLOBAL HOLDINGS INC (FRGE) Stock Fundamental Analysis

NYSE:FRGE - New York Stock Exchange, Inc. - US34629L1035 - Common Stock - Currency: USD

0.7504  -0.04 (-4.52%)

After market: 0.7401 -0.01 (-1.37%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to FRGE. FRGE was compared to 222 industry peers in the Capital Markets industry. The financial health of FRGE is average, but there are quite some concerns on its profitability. While showing a medium growth rate, FRGE is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

FRGE had negative earnings in the past year.
In the past year FRGE has reported a negative cash flow from operations.
FRGE Yearly Net Income VS EBIT VS OCF VS FCFFRGE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 -20M -40M -60M -80M -100M

1.2 Ratios

With a Return On Assets value of -27.65%, FRGE is not doing good in the industry: 96.77% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -32.61%, FRGE is doing worse than 88.48% of the companies in the same industry.
Industry RankSector Rank
ROA -27.65%
ROE -32.61%
ROIC N/A
ROA(3y)-22.68%
ROA(5y)N/A
ROE(3y)-26.69%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
FRGE Yearly ROA, ROE, ROICFRGE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 -10 -20 -30

1.3 Margins

FRGE has a Gross Margin of 99.32%. This is amongst the best in the industry. FRGE outperforms 99.54% of its industry peers.
In the last couple of years the Gross Margin of FRGE has grown nicely.
FRGE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 99.32%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.37%
GM growth 5YN/A
FRGE Yearly Profit, Operating, Gross MarginsFRGE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 50 -50 -100 -150

More info and screens

5

2. Health

2.1 Basic Checks

Compared to 1 year ago, FRGE has more shares outstanding
The debt/assets ratio for FRGE has been reduced compared to a year ago.
FRGE Yearly Shares OutstandingFRGE Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 50M 100M 150M
FRGE Yearly Total Debt VS Total AssetsFRGE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 100M 200M 300M

2.2 Solvency

FRGE has an Altman-Z score of 0.00. This is a bad value and indicates that FRGE is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of FRGE (0.00) is worse than 77.42% of its industry peers.
A Debt/Equity ratio of 0.03 indicates that FRGE is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.03, FRGE belongs to the best of the industry, outperforming 83.87% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 0
ROIC/WACCN/A
WACCN/A
FRGE Yearly LT Debt VS Equity VS FCFFRGE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 5.37 indicates that FRGE has no problem at all paying its short term obligations.
FRGE has a Current ratio of 5.37. This is amongst the best in the industry. FRGE outperforms 84.79% of its industry peers.
FRGE has a Quick Ratio of 5.37. This indicates that FRGE is financially healthy and has no problem in meeting its short term obligations.
FRGE's Quick ratio of 5.37 is amongst the best of the industry. FRGE outperforms 84.79% of its industry peers.
Industry RankSector Rank
Current Ratio 5.37
Quick Ratio 5.37
FRGE Yearly Current Assets VS Current LiabilitesFRGE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 50M 100M 150M 200M

More info and screens

6

3. Growth

3.1 Past

FRGE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 17.31%, which is quite good.
Looking at the last year, FRGE shows a quite strong growth in Revenue. The Revenue has grown by 18.08% in the last year.
FRGE shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.61% yearly.
EPS 1Y (TTM)17.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.09%
Revenue 1Y (TTM)18.08%
Revenue growth 3Y10.61%
Revenue growth 5YN/A
Sales Q2Q%3.52%

3.2 Future

FRGE is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.72% yearly.
FRGE is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 25.18% yearly.
EPS Next Y27.42%
EPS Next 2Y25.2%
EPS Next 3Y17.72%
EPS Next 5YN/A
Revenue Next Year16.06%
Revenue Next 2Y25.51%
Revenue Next 3Y25.18%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
FRGE Yearly Revenue VS EstimatesFRGE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 50M 100M
FRGE Yearly EPS VS EstimatesFRGE Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 -0.2 -0.4 -0.6

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

FRGE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for FRGE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FRGE Price Earnings VS Forward Price EarningsFRGE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
FRGE Per share dataFRGE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

A more expensive valuation may be justified as FRGE's earnings are expected to grow with 17.72% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y25.2%
EPS Next 3Y17.72%

More info and screens

0

5. Dividend

5.1 Amount

FRGE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FORGE GLOBAL HOLDINGS INC

NYSE:FRGE (1/29/2025, 8:27:12 PM)

After market: 0.7401 -0.01 (-1.37%)

0.7504

-0.04 (-4.52%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)11-06 2024-11-06/amc
Earnings (Next)N/A N/A
Inst Owners38.53%
Inst Owner Change0.12%
Ins Owners9.45%
Ins Owner Change-3.5%
Market Cap138.83M
Analysts78.33
Price Target3.75 (399.73%)
Short Float %1.96%
Short Ratio4.08
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)9.16%
Min EPS beat(2)-12.69%
Max EPS beat(2)31%
EPS beat(4)2
Avg EPS beat(4)-1.82%
Min EPS beat(4)-40.73%
Max EPS beat(4)31%
EPS beat(8)3
Avg EPS beat(8)-2.07%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-4.38%
Min Revenue beat(2)-15.84%
Max Revenue beat(2)7.08%
Revenue beat(4)1
Avg Revenue beat(4)-3.73%
Min Revenue beat(4)-15.84%
Max Revenue beat(4)7.08%
Revenue beat(8)2
Avg Revenue beat(8)-4.49%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-8.12%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.83%
EPS NY rev (1m)0%
EPS NY rev (3m)-8.72%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-17.51%
Revenue NY rev (1m)-0.15%
Revenue NY rev (3m)-8.37%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.74
P/FCF N/A
P/OCF N/A
P/B 0.59
P/tB 1.29
EV/EBITDA N/A
EPS(TTM)-0.43
EYN/A
EPS(NY)-0.22
Fwd EYN/A
FCF(TTM)-0.22
FCFYN/A
OCF(TTM)-0.21
OCFYN/A
SpS0.43
BVpS1.27
TBVpS0.58
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -27.65%
ROE -32.61%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 99.32%
FCFM N/A
ROA(3y)-22.68%
ROA(5y)N/A
ROE(3y)-26.69%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.37%
GM growth 5YN/A
F-Score3
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 17.83%
Cap/Sales 1.58%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.37
Quick Ratio 5.37
Altman-Z 0
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)59.45%
Cap/Depr(5y)N/A
Cap/Sales(3y)4.29%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.09%
EPS Next Y27.42%
EPS Next 2Y25.2%
EPS Next 3Y17.72%
EPS Next 5YN/A
Revenue 1Y (TTM)18.08%
Revenue growth 3Y10.61%
Revenue growth 5YN/A
Sales Q2Q%3.52%
Revenue Next Year16.06%
Revenue Next 2Y25.51%
Revenue Next 3Y25.18%
Revenue Next 5YN/A
EBIT growth 1Y6.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year52.72%
EBIT Next 3Y26%
EBIT Next 5YN/A
FCF growth 1Y39.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y36.47%
OCF growth 3YN/A
OCF growth 5YN/A